Tag: Pharmaceutical industry
Compounding Group Faces Legal Setback; Hims Stock Declines
A legal setback for a compounding group has caused a decline in Hims stock, stirring up the biotech industry. The ruling against the Outsourcing Facility Association, a compounding trade group, has impacted the production...
Pfizer and GSK DEI Changes, Pharma Tariffs: Pharmalittle News
Pfizer and GSK Make DEI Changes Amid Pharma Tariffs: A Look into Industry TransformationsAs another workweek comes to a close, the anticipation of weekend plans fills the air with promise. The prospect of catching...
Drugmakers’ Wish List: Meeting Trump’s Expectations in Healthcare
In a bold move that could potentially impact the entire pharmaceutical industry, Eli Lilly's CEO, Dave Ricks, recently announced plans to construct four manufacturing sites in the United States. This significant $27 billion investment...
Bill in Congress to Eliminate Small vs Large Molecule Drug Distinctions
In a recent development in Congress, lawmakers have put forth a bill aimed at amending a crucial aspect of the Inflation Reduction Act due to concerns that the current law is hindering investments in...
End of Novo Nordisk Ozempic and Wegovy Shortage
The Food and Drug Administration has officially announced the end of the shortage of Novo Nordisk’s popular drug semaglutide, a development that has significant implications for both patients and the pharmaceutical industry. This drug,...
Pfizer CEO Bourla’s Awkward Washington Encounter
Pfizer CEO Bourla's Awkward Washington EncounterBluebird Bio, a biotech company, recently made headlines by avoiding bankruptcy through a strategic sale to investment firms Carlyle and SK Capital. The deal, valued at less than $30...
Investigation Urged into Pharma Companies for Covid-19 Vaccine Claims
A U.K. Parliament member is urging regulators to investigate pharmaceutical companies for misleading claims about their Covid-19 vaccines. This call to action follows Moderna's reprimand by a U.K. trade group for its controversial recruitment...
California Democrats Debate Reining in Drug Industry Middlemen
The debate over reining in drug industry middlemen in California is heating up, with Governor Gavin Newsom and state legislators in Sacramento grappling with the high costs of prescription drugs. A recent proposal that...
Managing High Drug Costs: Strategies and Solutions
As the calendar flips to February 3, 2025, the latest episode of "An Arm and a Leg" delves into the pressing issue of managing high drug costs. Host Dan Weissmann sets the stage with...
Challenges of Accessing Effective Rare Disease Treatments
Cristina Brennan is facing a race against time. By the end of this year, her 12-year-old son Tristan will no longer have access to a crucial medicine that has been instrumental in managing his...
